[go: up one dir, main page]

NO924076L - Antihypertensive midler - Google Patents

Antihypertensive midler

Info

Publication number
NO924076L
NO924076L NO92924076A NO924076A NO924076L NO 924076 L NO924076 L NO 924076L NO 92924076 A NO92924076 A NO 92924076A NO 924076 A NO924076 A NO 924076A NO 924076 L NO924076 L NO 924076L
Authority
NO
Norway
Prior art keywords
lower alkyl
aryl
halogen
optionally substituted
antihypertensive agents
Prior art date
Application number
NO92924076A
Other languages
English (en)
Other versions
NO924076D0 (no
Inventor
Jose Repolles Moliner
Francisco Pubill Coy
Lydia Cabeza Llorente
Carlos Malet Falco
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of NO924076D0 publication Critical patent/NO924076D0/no
Publication of NO924076L publication Critical patent/NO924076L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Antihypertensive N-(a-substituert pyridinyl)karbonyl- dipeptidderivater med den generelle formel (I) <R3>n CONH¿CH-CON OOR, inkluderende farmasøytisk tålbare salter derav og tautomere former, hvori: n er O eller et helt tall fra l til 3; R er OH, SH, COOH, NH2. halogen, OR4 , SR4, COOR4, NHR4 eller N(R4>2. idet R4 er valgt fra eventuelt substituert lavere alkyl, aryl og acyl; R! står for OH, eventuelt substituert lavere alkoksy, aryl lavere alkoksy, aryloksy eller disubstituerte aminogrupper; R2 er valgt fra lavere alkyl og amino lavere alkyl; R3 står for halogen, NC>2, lavere alkyl, halogen lavere alkyl, aryl lavere alkyl eller aryl; De nevnte derivater er blant annet nyttige ved behandling av hypertensjon.
NO92924076A 1991-02-27 1992-10-21 Antihypertensive midler NO924076L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91102950A EP0500989B1 (en) 1991-02-27 1991-02-27 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents
PCT/EP1992/000400 WO1992015608A1 (en) 1991-02-27 1992-02-26 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS

Publications (2)

Publication Number Publication Date
NO924076D0 NO924076D0 (no) 1992-10-21
NO924076L true NO924076L (no) 1992-12-21

Family

ID=8206465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924076A NO924076L (no) 1991-02-27 1992-10-21 Antihypertensive midler

Country Status (18)

Country Link
US (1) US5432159A (no)
EP (1) EP0500989B1 (no)
JP (1) JPH05507295A (no)
AT (1) ATE174343T1 (no)
AU (1) AU650954B2 (no)
BR (1) BR9204779A (no)
CA (1) CA2081471A1 (no)
CZ (1) CZ280952B6 (no)
DE (1) DE69130605T2 (no)
ES (1) ES2037613B1 (no)
FI (1) FI924850L (no)
HU (1) HUT62313A (no)
NO (1) NO924076L (no)
PL (1) PL167915B1 (no)
PT (1) PT100148B (no)
RO (1) RO111369B1 (no)
RU (1) RU2098424C1 (no)
WO (1) WO1992015608A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5825094A (en) * 1993-11-19 1995-06-06 Astra Aktiebolag Novel dipeptide derivatives
EA003528B1 (ru) * 1997-04-04 2003-06-26 Пфайзер Продактс Инк. Производные никотинамида, их применение, фармацевтическая композиция, способ лечения и способ ингибирования изоферментов фдэ4 d
CZ292494B6 (cs) * 1998-09-22 2003-10-15 Kaneka Corporation Způsob výroby N2-(1(S)-karboxy-3-fenylpropyl)-L-lysyl-L-prolinu
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
BR0116850A (pt) 2001-01-31 2004-02-25 Pfizer Prod Inc Derivados de amida de ácido tiazolil-, oxazolil-, pirrolil- e imidazolil- úteis como inibidores de isoenzimas de pde4
PL364135A1 (en) 2001-01-31 2004-12-13 Pfizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
CN1527830A (zh) 2001-01-31 2004-09-08 �Ʒ� 用作pde4同工酶的抑制剂的醚衍生物
WO2003033471A1 (en) * 2001-10-17 2003-04-24 Tobishi Pharmaceutical Co.,Ltd Novel pyridone derivative and remedial agent for circulatory disease containing the same
US7153822B2 (en) * 2002-01-29 2006-12-26 Wyeth Compositions and methods for modulating connexin hemichannels
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
WO2006113199A1 (en) * 2005-04-14 2006-10-26 Merck & Co., Inc. Vla-4 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU537592B2 (en) * 1979-04-02 1984-07-05 E.R. Squibb & Sons, Inc. Mercaptoacyldipeptides
NZ202232A (en) * 1981-11-06 1985-08-16 Smithkline Beckman Corp N-carboxyalkylproline-containing tripeptides and pharmaceutical compositions
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
PT100148B (pt) 1999-06-30
HU9203324D0 (en) 1993-01-28
AU1278392A (en) 1992-10-06
FI924850A0 (fi) 1992-10-26
JPH05507295A (ja) 1993-10-21
PL167915B1 (pl) 1995-12-30
CZ280952B6 (cs) 1996-05-15
BR9204779A (pt) 1993-08-17
ATE174343T1 (de) 1998-12-15
US5432159A (en) 1995-07-11
CZ322092A3 (en) 1993-02-17
EP0500989B1 (en) 1998-12-09
DE69130605D1 (de) 1999-01-21
HUT62313A (en) 1993-04-28
WO1992015608A1 (en) 1992-09-17
PT100148A (pt) 1993-05-31
RU2098424C1 (ru) 1997-12-10
ES2037613B1 (es) 1994-03-16
AU650954B2 (en) 1994-07-07
ES2037613A1 (es) 1993-06-16
CA2081471A1 (en) 1992-08-28
DE69130605T2 (de) 1999-05-20
FI924850A7 (fi) 1992-10-26
EP0500989A1 (en) 1992-09-02
RO111369B1 (ro) 1996-09-30
FI924850L (fi) 1992-10-26
NO924076D0 (no) 1992-10-21
PL296625A1 (en) 1993-08-09

Similar Documents

Publication Publication Date Title
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
NL300086I1 (nl) Pyimidinederivaten en werkwijzen voor de bereidingervan.
NO307255B1 (no) Nye forbindelser og antitumormidler
NO924076L (no) Antihypertensive midler
DK0731085T3 (da) Stilbenderivater og farmaceutiske sammensætinger indeholdende disse
SE8201854L (sv) N-substituerade amino-aminosyror
ZA918893B (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,process for their production and pharmaceutical agents containing these derivatives
NO931166D0 (no) Piperdinderivater, deres fremstilling og anvendelse for terapi
PL291129A1 (en) Method of obtaining derivatives of thioalkylcephalosporin
NO942740D0 (no) Pyridinkarboksimidamid-forbindelse og anvendelse av samme
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
ES445874A1 (es) Procedimiento para la obtencion de 1-(indolil-3-alquil)-3- o-4-(ureido o guadino)-piperidinas.
HU9203431D0 (en) New phthalazines containing ehter- or thioether group in location 1 and method for producing them
ES8607953A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina
FI830186L (fi) Amidderivat
GR3015047T3 (en) Heterocyclic acyl aminodiol beta-amino acid derivatives.
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
EP0346465A4 (en) 1-carboxy-1-vyniloxyiminoaminothiazole cephalosporing derivatives and process for their preparation.
ATE181327T1 (de) Indolderivate
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
ES2103675A1 (es) Nuevas piperidinas sustituidas.
ATE96026T1 (de) Verwendung heterozyklischer amide zur verhinderung der tumormetastasierung.
TR199800039T1 (xx) Pirimidin n�kleozit t�revleri.
NO951985L (no) Acetamidderivat